Skip to main content
. 2014 Jan 30;144(1):133–142. doi: 10.1007/s10549-014-2842-9

Table 3.

Important characteristics for patients that did not receive (neo)adjuvant chemotherapy

Variable BRCA1/2 mutation carriers (n = 7) Noncarriers (n = 112)
TNM stage
 I 5 (71 %) 67 (60 %)
 II 2 (29 %) 39 (35 %)
 III 0 (0 %) 6 (5 %)
Tumor grade
 I 0 (0 %) 31 (35 %)
 II 1 (17 %) 33 (37 %)
 III 5 (83 %) 25 (28 %)
 Missing 1 23
ER status
 Negative 4 (100 %) 30 (32 %)
 Positive 0 (0 %) 63 (68 %)
 Missing 3 19